J7677Drugs Administered Other than Oral Method
Revefenacin inhalation solution, fda-approved final product, non-compounded,
Short description: Revefenacin inh non-com 1mcg
- Effective date
- July 1, 2019
- Termination date
- —
Related codes (J-series)
J0013Esketamine, nasal sprayJ0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injectionJ0121Inj., omadacycline, 1 mgJ0122Inj., eravacycline, 1 mgJ0129Abatacept injectionJ0130Abciximab injectionJ0131Inj, acetaminophen (nos)J0132Acetylcysteine injectionJ0133Acyclovir injectionJ0134Inj acetaminophen -freseniusJ0135Adalimumab injection
Frequently asked questions
What is HCPCS code J7677?
J7677 is a HCPCS Level II code for Revefenacin inhalation solution, fda-approved final product, non-compounded,.
What category is HCPCS code J7677 in?
J7677 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.
When did HCPCS code J7677 become effective?
J7677 has been effective since July 1, 2019, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.